NCT00048607View on ClinicalTrials.gov

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

July 30, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Major Depressive Disorder
Interventions
DRUG

aprepitant

DRUG

Comparator: paroxetine HCL

DRUG

Comparator: Placebo (Unspecified)

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00048607 - Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) | Biotech Hunter | Biotech Hunter